Ordering patient medications is easy. With an online account, access our extensive formulary or over 40,000 unique items - 24 hours a day, 7 days a week.
Ordering your pet's prescription drugs from Wedgewood Pharmacy is safe, and convenient. With a prescription number, easily refill prescriptions and enroll in the AutoRefill Program.
Mitotane is an adrenal cytotoxic drug that is derived from the insecticide DDT. It commonly is used to treat PDH in dogs. Mitotane causes severe, progressive, cellular necrosis of the
zona fasciculata and the zona reticularis. To a much lesser degree it also may affect the zona glomerulosa. Mitotane also may inhibit adrenocortical function without causing cell death, although in this case the mechanism of action is not known. Mitotane is stored in body fat, metabolized by the liver, and excreted in both bile and urine.
We can let your veterinarian know that you are interested in our compounded Mitotane.
Cushing’s Disease is one of the most-common endocrine disorders in dogs and within that group, 80 - 85% of the dogs have PDH, while the remaining 15% have a functional adrenal tumor. Mitotane is a commonly used treatment for PDH in dogs and approximately 80% of dogs with PDH will respond favorably to treatment. There are two different basic protocols for using mitotane in dogs with PDH. The traditional and more commonly used protocol has an induction period of about seven to 10 days followed by weekly treatments. The second protocol is a medical adrenalectomy using mitotane to destroy the adrenal cortex with the commitment to lifetime supplementation.
In the traditional protocol, about 25% of dogs will experience some adverse side-effects during the induction phase. These usually occur when the plasma cortisol decreases too rapidly or is less than 1 microgram/dl. Small dogs, particularly those weighing less than 5kg, are more likely to experience adverse side-effects. There are different schools of thought regarding the use of exogenous prednisone during the initial treatment. The rational for this practice is to reduce the possibility of side effects due to the rapid decline of endogenous steroid.
There is a great deal of individual variation in sensitivity to mitotane; owners will need to be educated to possible signs of hypoadrenocorticism. Dogs that are being treated for PDH will require medication and monitoring for the rest of their lives. Most dogs will require gradually increasing doses of mitotane in order to remain in remission. The oral absorption of mitotane is poor. It is enhanced by giving the drug with food, particularly food with a high fat or oil content. Some clinicians recommend coating the pill with vegetable oil before giving with a meal.
Although mitotane has been used in cats, it rarely is effective. The treatment of choice in cats is adrenalectomy and supplementation with mineralocorticoids and glucocorticoids.
The likelihood of side effects may be decreased by dividing the daily dose and administering at eight- to 12-hour intervals. The most-common side effects include lethargy, gastritis, anorexia, vomiting, and diarrhea. Although less common, hypoadrenalcorticism and an addisonian crisis also are potential side effects. In rare instances, dogs may experience central nervous system (CNS) signs, ataxia, weakness, and seizures.
Mitotane has both a long half-life and is toxic to the adrenals. If recognized promptly, overdose should be treated aggressively with gut-emptying protocols, activated charcoal, and a cathartic. The patient should be followed closely and receive corticosteroids as necessary.
May Be Prescribed by Veterinarians for:
Pituitary-dependent hyper-adrenocorticism (PDH)
Search for Available Dosage Forms
Barbara Forney, VMD
Dr. Barbara Forney is a veterinary practitioner in Chester County, Pennsylvania. She has a master's degree in animal science from the University of Delaware and graduated from the University of Pennsylvania School of Veterinary Medicine in 1982.
She began to develop her interest in client education and medical writing in 1997. Recent publications include portions of The Pill Book Guide to Medication for Your Dog and Cat, and most recently Understanding Equine Medications published by the Bloodhorse.
Dr. Forney is an FEI veterinarian and an active member of the AAEP, AVMA, and AMWA.
Some states restrict the information we may provide about controlled substances. Please select your state below.
405 HERON DRIVE SUITE 200 • SWEDESBORO, NJ 08085-1749 | © 2004-2021 WEDGEWOOD PHARMACY, ALL RIGHTS RESERVED.
This content is intended for counseling purposes only. This content is informational/educational and is not intended to treat or diagnose any disease or patient. No claims are made as to the safety or efficacy of mentioned preparations. The compounded medications featured in this content have been prescribed and/or administered by prescribers who work with Wedgewood Pharmacy. You are encouraged to speak with your prescriber as to the appropriate use of any medication. Wedgewood Pharmacy’s compounded veterinary preparations are not intended for use in food and food-producing animals. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.